about
Vascular endothelial growth factor stimulates rat cholangiocyte proliferation via an autocrine mechanismGABA induces the differentiation of small into large cholangiocytes by activation of Ca(2+) /CaMK I-dependent adenylyl cyclase 8.Recent advances in the regulation of cholangiocyte proliferation and function during extrahepatic cholestasisAfter damage of large bile ducts by gamma-aminobutyric acid, small ducts replenish the biliary tree by amplification of calcium-dependent signaling and de novo acquisition of large cholangiocyte phenotypes.Role of follicle-stimulating hormone on biliary cyst growth in autosomal dominant polycystic kidney disease.Taurocholic acid prevents biliary damage induced by hepatic artery ligation in cholestatic rats.Polycystic liver diseases.Prolonged exposure of cholestatic rats to complete dark inhibits biliary hyperplasia and liver fibrosis.Caffeic acid phenethyl ester decreases cholangiocarcinoma growth by inhibition of NF-kappaB and induction of apoptosis.Neuropeptide Y inhibits cholangiocarcinoma cell growth and invasion.Chelidonium majus is not hepatotoxic in Wistar rats, in a 4 weeks feeding experiment.Secretin inhibits cholangiocarcinoma growth via dysregulation of the cAMP-dependent signaling mechanisms of secretin receptor.Role of docosahexaenoic acid treatment in improving liver histology in pediatric nonalcoholic fatty liver disease.Gonadotropin-releasing hormone stimulates biliary proliferation by paracrine/autocrine mechanismsProfiles of cancer stem cell subpopulations in cholangiocarcinomas.Activation of alpha(1) -adrenergic receptors stimulate the growth of small mouse cholangiocytes via calcium-dependent activation of nuclear factor of activated T cells 2 and specificity protein 1.Morphological and functional features of hepatic cyst epithelium in autosomal dominant polycystic kidney disease.Progesterone stimulates the proliferation of female and male cholangiocytes via autocrine/paracrine mechanismsSmall mouse cholangiocytes proliferate in response to H1 histamine receptor stimulation by activation of the IP3/CaMK I/CREB pathway.Serotonin metabolism is dysregulated in cholangiocarcinoma, which has implications for tumor growthNeuropeptide Y inhibits biliary hyperplasia of cholestatic rats by paracrine and autocrine mechanisms.Morphological and functional heterogeneity of the mouse intrahepatic biliary epitheliumTaurocholate feeding to bile duct ligated rats prevents caffeic acid-induced bile duct damage by changes in cholangiocyte VEGF expression.Endothelin inhibits cholangiocarcinoma growth by a decrease in the vascular endothelial growth factor expressionNew insights into liver stem cells.Melatonin inhibits cholangiocyte hyperplasia in cholestatic rats by interaction with MT1 but not MT2 melatonin receptors.Increased local dopamine secretion has growth-promoting effects in cholangiocarcinoma.H3 histamine receptor-mediated activation of protein kinase Calpha inhibits the growth of cholangiocarcinoma in vitro and in vivo.Secretin stimulates biliary cell proliferation by regulating expression of microRNA 125b and microRNA let7a in mice.Anandamide inhibits cholangiocyte hyperplastic proliferation via activation of thioredoxin 1/redox factor 1 and AP-1 activation.Biliary tree stem/progenitor cells in glands of extrahepatic and intraheptic bile ducts: an anatomical in situ study yielding evidence of maturational lineages.Effect of ovariectomy on the proliferative capacity of intrahepatic rat cholangiocytes.Intracellular pathways mediating estrogen-induced cholangiocyte proliferation in the rat.Evidence for multipotent endodermal stem/progenitor cell populations in human gallbladder.Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantationActivation of the IGF1 System Characterizes Cholangiocyte Survival During Progression of Primary Biliary CirrhosisEffect of taurohyodeoxycholic acid, a hydrophilic bile salt, on bile salt and biliary lipid secretion in the ratHepatic progenitor cells activation, fibrosis, and adipokines production in pediatric nonalcoholic fatty liver diseaseEffects of low power 904 nm radiation on rat fibroblasts explanted and in vitro culturedLiver metabolic zonation and hepatic microcirculation in carbon tetrachloride-induced experimental cirrhosis
P50
Q28573364-956CB285-0133-4DC0-9B3C-116D8D2A5E95Q30542145-D901E067-25DE-4A0A-B017-FEBEF21B3891Q33718790-B73982FA-1CC4-4D4C-814B-F37BD9501FD3Q33745195-F5ABD1F1-21C8-43C0-9696-632737A9B900Q33783730-AD9BD1EE-5752-443A-801F-05C845FCF587Q33936280-FFD07CC7-2285-49FF-8200-90FEA26455FAQ33949172-3FDC36A4-8B36-474D-A56F-529EE92CB701Q34439817-3061E0E0-224C-4A92-91B8-297F66C88AC9Q34636044-21008AFC-EE99-43AF-AC75-D3F617D440E3Q34979300-C325A419-B0BC-4DE6-9155-9C2D17126FF5Q35003665-5DCDED0F-0199-4424-9FEE-63BBCAE904E6Q35012302-5976D0B3-2CC1-45F4-9155-AF47856E8156Q35088371-D820295F-A96F-4643-B4F9-83BBD3980A5AQ35236464-3DD3F02B-2B28-4590-AFD7-2B681C09DFBEQ35669078-3E8236AA-9BC7-41CF-B257-635B49A3A801Q36466409-B15C2ED5-1C69-4C4E-B8E9-54B1F99F5C1AQ36559639-74E266CD-362D-4592-B059-29CB593F634FQ36807790-880C3BC3-E95A-4192-B6CC-58C6C07C34CEQ36842314-D0A088C1-13D5-4DB6-A46B-FD6FBA9E9C38Q36996185-A11F4151-4677-4A1C-8C7E-0061684A3D28Q37093626-D92514DF-4B0F-418B-97A4-41D0825EE60EQ37142524-0A2B3993-8D0D-482D-8194-1BD0376C3027Q37157705-3F71F486-9A9C-4E12-B71A-765D49339C8EQ37253350-9732FC2E-6990-49D5-A115-9420D7C1DF07Q37464439-F0128570-49CC-4347-B4E1-218F059BF132Q38682140-26300B14-524F-447C-A81C-FB5D95D677AFQ39340369-807FBF1B-32D1-4822-872D-762D6E43116DQ39787871-EDDC7A0B-8107-4420-8603-992B588E8C6CQ39979273-7F3E3A5F-5E65-42B1-B2D1-C911B8310344Q40032518-E31443F8-F1EC-4815-B641-9B00DA85F41EQ40962891-4A98240F-A3C6-448A-876E-0107A59947D7Q44054049-E8B3B2AB-E9DA-419C-92C8-13DD68BA8778Q44080024-4F50475A-BCFC-40FC-8D53-DD7FEB9B68DCQ53066287-C4F0ECC2-F5A5-4EAA-B53A-F2346298F937Q56101274-C5D2387A-1B17-48BE-B41C-76ED68B1613EQ57791888-F71F08BC-C283-4110-A5CD-EA2CDEEC3F29Q57792151-B6B4B061-3149-4349-B8DA-04027D9A92CCQ62066904-51170EEE-1779-411F-A067-03DF994B0B43Q72577715-7D2C4BF9-1195-4EC8-91E8-F7250031F345Q73014275-44862A73-0F8C-4193-AE0A-2A3A4D85DD2E
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0003-0822-3690
@en
name
Antonio Franchitto
@ast
Antonio Franchitto
@en
Antonio Franchitto
@es
Antonio Franchitto
@nl
type
label
Antonio Franchitto
@ast
Antonio Franchitto
@en
Antonio Franchitto
@es
Antonio Franchitto
@nl
prefLabel
Antonio Franchitto
@ast
Antonio Franchitto
@en
Antonio Franchitto
@es
Antonio Franchitto
@nl
P106
P1153
6701756460
P21
P31
P496
0000-0003-0822-3690